Sjs Investment Consulting Inc. Halozyme Therapeutics, Inc. Transaction History
Sjs Investment Consulting Inc.
- $499 Million
- Q2 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 21 shares of HALO stock, worth $1,180. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 21
-0.0%
Holding current value
$1,180
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HALO
# of Institutions
457Shares Held
123MCall Options Held
216KPut Options Held
129K-
Black Rock Inc. New York, NY18.2MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$734 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$365 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$232 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$213 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.83B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...